ACS Publications. Most Trusted. Most Cited. Most Read

OR SEARCH CITATIONS

My Activity
Publications
CONTENT TYPES

Figure 1Loading Img
Download Hi-Res ImageDownload to MS-PowerPointCite This:J. Med. Chem. 2016, 59, 16, 7389-7409
RETURN TO ISSUEPREVPerspectiveNEXT

Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?

View Author Information
FORUM Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States
*E-mail: [email protected]
Cite this: J. Med. Chem. 2016, 59, 16, 7389–7409
Publication Date (Web):March 23, 2016
https://doi.org/10.1021/acs.jmedchem.5b01960
Copyright © 2016 American Chemical Society
RIGHTS & PERMISSIONS

Article Views

3969

Altmetric

-

Citations

103
LEARN ABOUT THESE METRICS
Read OnlinePDF (2 MB)
Get e-Alerts
SUBJECTS:

Abstract

Abstract Image

The rapidly aging population desperately requires new therapies for Alzheimer’s disease. Despite years of pharmaceutical research, limited clinical success has been realized, with several failed disease modification therapies in recent years. On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its production. In this Perspective, we focus on the development of small molecules that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concentration of the shorter non-amyloidogenic Aβ species. After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clinical proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system multiparameter optimization scores, and high sp3 character.

Cited By

This article is cited by 103 publications.

  1. Sanjay Bhattarai, Sujan Devkota, Michael S. Wolfe. Design of Transmembrane Mimetic Structural Probes to Trap Different Stages of γ-Secretase–Substrate Interaction. Journal of Medicinal Chemistry 2021, 64 (20) , 15367-15378. https://doi.org/10.1021/acs.jmedchem.1c01395
  2. Matthew G. Bursavich, Bryce A. Harrison, Raksha Acharya, Donald E. Costa, Emily A. Freeman, Lori A. Hrdlicka, Hong Jin, Sudarshan Kapadnis, Jeffrey S. Moffit, Deirdre Murphy, Scott J. Nolan, Holger Patzke, Cuyue Tang, Hilliary E. Van Voorhies, Melody Wen, Gerhard Koenig, Jean-François Blain, Duane A. Burnett. Discovery of the Oxadiazine FRM-024: A Potent CNS-Penetrant Gamma Secretase Modulator. Journal of Medicinal Chemistry 2021, 64 (19) , 14426-14447. https://doi.org/10.1021/acs.jmedchem.1c00904
  3. Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, Laura Dominguez. Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. ACS Chemical Neuroscience 2021, 12 (15) , 2765-2775. https://doi.org/10.1021/acschemneuro.1c00313
  4. Bryan Li, Richard W. Barnhart, Amelie Dion, Steven Guinness, Alan Happe, Cheryl M. Hayward, Jeffrey Kohrt, Teresa Makowski, Mark Maloney, Jade D. Nelson, Asaad Nematalla, J. Christopher McWilliams, Zhihui Peng, Jeffrey Raggon, John Sagal, Gerald A. Weisenburger, Denghui Bao, Miguel Gonzalez, Jiangping Lu, Mark D. McLaws, Jian Tao, Baolin Wu. Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor—Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors. Organic Process Research & Development 2021, 25 (6) , 1440-1453. https://doi.org/10.1021/acs.oprd.1c00126
  5. Biao Zhang, Donghan Liu, Yulin Sun, Yajing Zhang, Jiayi Feng, Fuchao Yu. Preparation of Thiazole-2-thiones through TBPB-Promoted Oxidative Cascade Cyclization of Enaminones with Elemental Sulfur. Organic Letters 2021, 23 (8) , 3076-3082. https://doi.org/10.1021/acs.orglett.1c00751
  6. Wenjie Luo, Fanny C. F. Ip, Guangmiao Fu, Kit Cheung, Yuan Tian, Yueqing Hu, Anjana Sinha, Elaine Y. L. Cheng, Xianzhong Wu, Victor Bustos, Paul Greengard, Yue-Ming Li, Subhash C. Sinha, Nancy Y. Ip. A Pentacyclic Triterpene from Ligustrum lucidum Targets γ-Secretase. ACS Chemical Neuroscience 2020, 11 (18) , 2827-2835. https://doi.org/10.1021/acschemneuro.0c00389
  7. Rosa María Rodríguez Sarmiento, Caterina Bissantz, Johan Bylund, Anja Limberg, Werner Neidhart, Roland Jakob-Roetne, Lisha Wang, Karlheinz Baumann. Stepwise Design of γ-Secretase Modulators with an Advanced Profile by Judicious Coordinated Structural Replacements and an Unconventional Phenyl Ring Bioisostere. Journal of Medicinal Chemistry 2020, 63 (15) , 8534-8553. https://doi.org/10.1021/acs.jmedchem.0c00909
  8. Hasane Ratni, Andre Alker, Bjoern Bartels, Caterina Bissantz, Weichun Chen, Irene Gerlach, Anja Limberg, Mingqiu Lu, Werner Neidhart, Solen Pichereau, Michael Reutlinger, Rosa-Maria Rodriguez-Sarmiento, Roland Jakob-Roetne, Georg Schmitt, Eric Zhang, Karlheinz Baumann. Discovery of RO7185876, a Highly Potent γ-Secretase Modulator (GSM) as a Potential Treatment for Alzheimer’s Disease. ACS Medicinal Chemistry Letters 2020, 11 (6) , 1257-1268. https://doi.org/10.1021/acsmedchemlett.0c00109
  9. Hester A. Beard, Marta Barniol-Xicota, Jian Yang, Steven H. L. Verhelst. Discovery of Cellular Roles of Intramembrane Proteases. ACS Chemical Biology 2019, 14 (11) , 2372-2388. https://doi.org/10.1021/acschembio.9b00404
  10. Michael S. Wolfe. Structure and Function of the γ-Secretase Complex. Biochemistry 2019, 58 (27) , 2953-2966. https://doi.org/10.1021/acs.biochem.9b00401
  11. Kenneth M. Boy, Jason M. Guernon, Dmitry S. Zuev, Li Xu, Yunhui Zhang, Jianliang Shi, Lawrence R. Marcin, Mendi A. Higgins, Yong-Jin Wu, Subramaniam Krishnananthan, Jianqing Li, Ashok Trehan, Daniel Smith, Jeremy H. Toyn, Jere E. Meredith, Catherine R. Burton, S. Roy Kimura, Tatyana Zvyaga, Xiaoliang Zhuo, Kimberley A. Lentz, James E. Grace, Rex Denton, John S. Morrison, Arvind Mathur, Charles F. Albright, Michael K. Ahlijanian, Richard E. Olson, Lorin A. Thompson, John E. Macor. Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481. ACS Medicinal Chemistry Letters 2019, 10 (3) , 312-317. https://doi.org/10.1021/acsmedchemlett.8b00541
  12. Ning Tang, Arun K. Somavarapu, Kasper P. Kepp. Molecular Recipe for γ-Secretase Modulation from Computational Analysis of 60 Active Compounds. ACS Omega 2018, 3 (12) , 18078-18088. https://doi.org/10.1021/acsomega.8b02196
  13. Kenji Nakahara, Kouki Fuchino, Kazuo Komano, Naoya Asada, Genta Tadano, Tsuyoshi Hasegawa, Takahiko Yamamoto, Yusuke Sako, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, Ken-ichi Kusakabe. Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization. Journal of Medicinal Chemistry 2018, 61 (13) , 5525-5546. https://doi.org/10.1021/acs.jmedchem.8b00011
  14. Kouki Fuchino, Yasunori Mitsuoka, Moriyasu Masui, Noriyuki Kurose, Shuhei Yoshida, Kazuo Komano, Takahiko Yamamoto, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Hirofumi Miyajima, Shuichi Hiroyama, Kiyotaka Koyabu, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, Ken-ichi Kusakabe. Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain. Journal of Medicinal Chemistry 2018, 61 (12) , 5122-5137. https://doi.org/10.1021/acs.jmedchem.8b00002
  15. Danica A. Rankic, Cory M. Stiff, Christopher W. am Ende, and John M. Humphrey . Protocol for the Direct Conversion of Lactones to Lactams Mediated by 1,5,7-Triazabicyclo[4.4.0]dec-5-ene: Synthesis of Pyridopyrazine-1,6-diones. The Journal of Organic Chemistry 2017, 82 (23) , 12791-12797. https://doi.org/10.1021/acs.joc.7b02079
  16. Abhijeet Srivastava, Gaurav Shukla, Dhananjay Yadav, and Maya Shankar Singh . Access to Fully Substituted Thiazoles and 2,3-Dihydrothiazoles via Copper-Catalyzed [4 + 1] Heterocyclization of α-(N-Hydroxy/aryl)imino-β-oxodithioesters with α-Diazocarbonyls. The Journal of Organic Chemistry 2017, 82 (20) , 10846-10854. https://doi.org/10.1021/acs.joc.7b01601
  17. Zhiqiang Zhao, Dmitri A. Pissarnitski, Xianhai Huang, Anandan Palani, Zhaoning Zhu, William J. Greenlee, Lynn A. Hyde, Lixin Song, Giuseppe Terracina, Lili Zhang, and Eric M. Parker . Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators. ACS Medicinal Chemistry Letters 2017, 8 (10) , 1002-1006. https://doi.org/10.1021/acsmedchemlett.7b00178
  18. Matthew G. Bursavich, Bryce A. Harrison, Raksha Acharya, Donald E. Costa, Emily A. Freeman, Hilliary E. Hodgdon, Lori A. Hrdlicka, Hong Jin, Sudarshan Kapadnis, Jeffrey S. Moffit, Deirdre A. Murphy, Scott Nolan, Holger Patzke, Cuyue Tang, Melody Wen, Gerhard Koenig, Jean-François Blain, and Duane A. Burnett . Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease. Journal of Medicinal Chemistry 2017, 60 (6) , 2383-2400. https://doi.org/10.1021/acs.jmedchem.6b01620
  19. Felicia Liana Andronie-Cioara, Adriana Ioana Ardelean, Carmen Delia Nistor-Cseppento, Anamaria Jurcau, Maria Carolina Jurcau, Nicoleta Pascalau, Florin Marcu. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression. International Journal of Molecular Sciences 2023, 24 (3) , 1869. https://doi.org/10.3390/ijms24031869
  20. Alena V. Savonenko, Philip C. Wong, Tong Li. Alzheimer diseases. 2023, 313-336. https://doi.org/10.1016/B978-0-323-85654-6.00022-8
  21. Joanna E. Luo, Yue-Ming Li. Turning the tide on Alzheimer’s disease: modulation of γ-secretase. Cell & Bioscience 2022, 12 (1) https://doi.org/10.1186/s13578-021-00738-7
  22. T. Premkumar, S. Sajitha Lulu. Molecular Mechanisms of Emerging Therapeutic Targets in Alzheimer’s Disease: A Systematic Review. Neurochemical Journal 2022, 16 (4) , 443-455. https://doi.org/10.1134/S1819712422040183
  23. Pinky Gehlot, Sunil Kumar, Vivek Kumar Vyas, Bhanwar Singh Choudhary, Manish Sharma, Ruchi Malik. Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review. Bioorganic & Medicinal Chemistry 2022, 74 , 117047. https://doi.org/10.1016/j.bmc.2022.117047
  24. Michael S Wolfe. γ-Secretase as a drug target for familial Alzheimer's disease: the road less traveled. Future Medicinal Chemistry 2022, 14 (19) , 1341-1343. https://doi.org/10.4155/fmc-2022-0178
  25. Zahra Sayevand, Farzad Nazem, Afshin Nazari, Mohsen Sheykhlouvand, Scott C. Forbes. Cardioprotective effects of exercise and curcumin supplementation against myocardial ischemia–reperfusion injury. Sport Sciences for Health 2022, 18 (3) , 1011-1019. https://doi.org/10.1007/s11332-021-00886-w
  26. Yuxuan Dai, Chenyi Lei, Zhenhao Zhang, Yan Qi, Kejing Lao, Xingchun Gou. Amyloid-beta Targeted Therapeutic Approaches for Alzheimer’s Disease: Long Road Ahead. Current Drug Targets 2022, 23 (11) , 1040-1056. https://doi.org/10.2174/1389450123666220421124030
  27. Xianhai Huang, Robert Aslanian. Finding Cures for Alzheimer's Disease. 2022, 51-83. https://doi.org/10.1002/9781119627784.ch4
  28. Jiachen Wen, Dan Liu, Linxiang Zhao. Small molecules targeting γ-secretase and their potential biological applications. European Journal of Medicinal Chemistry 2022, 232 , 114169. https://doi.org/10.1016/j.ejmech.2022.114169
  29. Karolina Wojtunik-Kulesza, Tomasz Oniszczuk, Jarosław Mołdoch, Iwona Kowalska, Jarosław Szponar, Anna Oniszczuk. Selected Natural Products in Neuroprotective Strategies for Alzheimer’s Disease—A Non-Systematic Review. International Journal of Molecular Sciences 2022, 23 (3) , 1212. https://doi.org/10.3390/ijms23031212
  30. Rukmankesh Mehra, Kasper Planeta Kepp. Understanding familial Alzheimer's disease: The fit‐stay‐trim mechanism of γ‐secretase. WIREs Computational Molecular Science 2022, 12 (1) https://doi.org/10.1002/wcms.1556
  31. Danko Jeremic, Lydia Jiménez-Díaz, Juan D. Navarro-López. Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review. Ageing Research Reviews 2021, 72 , 101496. https://doi.org/10.1016/j.arr.2021.101496
  32. Sanjay Bhattarai, Lei Liu, Michael S. Wolfe. Discovery of aryl aminothiazole γ-secretase modulators with novel effects on amyloid β-peptide production. Bioorganic & Medicinal Chemistry Letters 2021, 54 , 128446. https://doi.org/10.1016/j.bmcl.2021.128446
  33. Navatha Shree Sharma, Anik Karan, Donghee Lee, Zheng Yan, Jingwei Xie. Advances in Modeling Alzheimer's Disease In Vitro. Advanced NanoBiomed Research 2021, 1 (12) https://doi.org/10.1002/anbr.202100097
  34. Kazuya Kobayashi, Takuya Otani, Saki Ijiri, Yuki Kawasaki, Hiroki Matsubara, Takahiro Miyagi, Taishi Kitajima, Risa Iseki, Katsuyasu Ishizawa, Naoka Shindo, Kouta Okawa, Kouta Ueda, Syun Ando, Momoka Kawakita, Yasunao Hattori, Kenichi Akaji. Structure–activity relationship study of hydroxyethylamine isostere and P1′ site structure of peptide mimetic BACE1 inhibitors. Bioorganic & Medicinal Chemistry 2021, 50 , 116459. https://doi.org/10.1016/j.bmc.2021.116459
  35. Tetsuo Cai, Taisuke Tomita. Sequential conformational changes in transmembrane domains of presenilin 1 in Aβ42 downregulation. The Journal of Biochemistry 2021, 170 (2) , 215-227. https://doi.org/10.1093/jb/mvab033
  36. Micaela Riscado, Bruno Baptista, Fani Sousa. New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics. Pharmaceutics 2021, 13 (9) , 1397. https://doi.org/10.3390/pharmaceutics13091397
  37. Boris Decourt, Fadel Boumelhem, Evans D. Pope, Jiong Shi, Zoltan Mari, Marwan Noel Sabbagh. Critical Appraisal of Amyloid Lowering Agents in AD. Current Neurology and Neuroscience Reports 2021, 21 (8) https://doi.org/10.1007/s11910-021-01125-y
  38. Michael S. Wolfe. Targeting γ-secretase for familial Alzheimer’s disease. Medicinal Chemistry Research 2021, 30 (7) , 1321-1327. https://doi.org/10.1007/s00044-021-02744-3
  39. Kejing Lao, Ruisan Zhang, Yuxuan Dai, Jing Luan, Na Guo, Xi Xu, Yuelin Zhang, Xingchun Gou. Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease. Molecular and Cellular Neuroscience 2021, 114 , 103630. https://doi.org/10.1016/j.mcn.2021.103630
  40. Milan Stoiljkovic, Tamas L. Horvath, Mihály Hajós. Therapy for Alzheimer’s disease: Missing targets and functional markers?. Ageing Research Reviews 2021, 68 , 101318. https://doi.org/10.1016/j.arr.2021.101318
  41. H. Ratni, K. Baumann, P. Bellotti, X. A. Cook, L. G. Green, T. Luebbers, M. Reutlinger, A. F. Stepan, W. Vifian. Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease. RSC Medicinal Chemistry 2021, 12 (5) , 758-766. https://doi.org/10.1039/D1MD00043H
  42. Alvaro Miranda, Enrique Montiel, Henning Ulrich, Cristian Paz, . Selective Secretase Targeting for Alzheimer’s Disease Therapy. Journal of Alzheimer's Disease 2021, 81 (1) , 1-17. https://doi.org/10.3233/JAD-201027
  43. Stefan Saretz, Gabriele Basset, Liridona Useini, Markus Laube, Jens Pietzsch, Dijana Drača, Danijela Maksimović-Ivanić, Johannes Trambauer, Harald Steiner, Evamarie Hey-Hawkins. Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue. Molecules 2021, 26 (10) , 2843. https://doi.org/10.3390/molecules26102843
  44. Kejing Lao, Ruisan Zhang, Jing Luan, Yuelin Zhang, Xingchun Gou. Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease. Journal of Alzheimer's Disease 2021, 79 (4) , 1429-1442. https://doi.org/10.3233/JAD-200851
  45. Rukmankesh Mehra, Kasper P. Kepp. Computational prediction and molecular mechanism of γ-secretase modulators. European Journal of Pharmaceutical Sciences 2021, 157 , 105626. https://doi.org/10.1016/j.ejps.2020.105626
  46. Samarpan Majumder, Judy S. Crabtree, Todd E. Golde, Lisa M. Minter, Barbara A. Osborne, Lucio Miele. Targeting Notch in oncology: the path forward. Nature Reviews Drug Discovery 2021, 20 (2) , 125-144. https://doi.org/10.1038/s41573-020-00091-3
  47. Haizhou Zhu, Venkateshwara Dronamraju, Wei Xie, Swati S. More. Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. Medicinal Chemistry Research 2021, 30 (2) , 305-352. https://doi.org/10.1007/s00044-020-02687-1
  48. Gerhard Multhaup, Filip Liebsch. Alzheimer’s Disease. 2021, 84-89. https://doi.org/10.1007/978-3-030-57401-7_262
  49. Guanghui Yang, Rui Zhou, Xuefei Guo, Chuangye Yan, Jianlin Lei, Yigong Shi. Structural basis of γ-secretase inhibition and modulation by small molecule drugs. Cell 2021, 184 (2) , 521-533.e14. https://doi.org/10.1016/j.cell.2020.11.049
  50. Frédéric Checler, Elissa Afram, Raphaëlle Pardossi-Piquard, Inger Lauritzen. Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?. Journal of Biological Chemistry 2021, 296 , 100489. https://doi.org/10.1016/j.jbc.2021.100489
  51. Michael S. Wolfe. Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease. Molecules 2021, 26 (2) , 388. https://doi.org/10.3390/molecules26020388
  52. Dominika Nowak, Wojciech Słupski, Maria Rutkowska. Nowe strategie terapeutyczne choroby Alzheimera. Postępy Higieny i Medycyny Doświadczalnej 2021, 75 (1) , 474-490. https://doi.org/10.5604/01.3001.0014.9532
  53. Kristi Henjum, Vibeke Årskog, Charlotte B. Jendresen, Tormod Fladby, Reidun Torp, Lars N. G. Nilsson. Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody. Scientific Reports 2020, 10 (1) https://doi.org/10.1038/s41598-020-67419-2
  54. Shin-Hann Lee, Sarah M. Gomes, Judy Ghalayini, Konstantin G. Iliadi, Gabrielle L. Boulianne. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Rescue Memory Defects in Drosophila -Expressing Alzheimer’s Disease-Related Transgenes Independently of the Canonical Renin Angiotensin System. eneuro 2020, 7 (6) , ENEURO.0235-20.2020. https://doi.org/10.1523/ENEURO.0235-20.2020
  55. Shekar Mekala, Grady Nelson, Yue-Ming Li. Recent developments of small molecule γ-secretase modulators for Alzheimer's disease. RSC Medicinal Chemistry 2020, 11 (9) , 1003-1022. https://doi.org/10.1039/D0MD00196A
  56. Jie Lei, Jia Xu, Dian-Yong Tang, Jing-Wei Shao, Hong-yu Li, Zhong-Zhu Chen, Zhi-Gang Xu. A concise and unexpected one-pot methodology for the synthesis of pyrazinone-fused pyridones. Organic Chemistry Frontiers 2020, 7 (18) , 2657-2663. https://doi.org/10.1039/D0QO00590H
  57. Christopher Lee, Stephanie M. Willerth, Haakon B. Nygaard. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer’s Disease Modeling. Progress in Neurobiology 2020, 192 , 101804. https://doi.org/10.1016/j.pneurobio.2020.101804
  58. Akio Fukumori, Lukas P. Feilen, Harald Steiner. Substrate recruitment by γ-secretase. Seminars in Cell & Developmental Biology 2020, 105 , 54-63. https://doi.org/10.1016/j.semcdb.2020.03.006
  59. Srishti Sharma, Manoj Kumar Banjare, Namrata Singh, Jan Korábečný, Zdeněk Fišar, Kamil Kuča, Kallol K. Ghosh. Exploring spectroscopic insights into molecular recognition of potential anti-Alzheimer's drugs within the hydrophobic pockets of β-cycloamylose. Journal of Molecular Liquids 2020, 311 , 113269. https://doi.org/10.1016/j.molliq.2020.113269
  60. M. Adel Youssef, Siva S. Panda, Riham A. El-Shiekh, ElSayed M. Shalaby, Dalia R. Aboshouk, Walid Fayad, Nehmedo G. Fawzy, Adel S. Girgis. Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2′-pyrrolidine-3′,3′′-pyrrolidines]. RSC Advances 2020, 10 (37) , 21830-21838. https://doi.org/10.1039/D0RA03064C
  61. Xinyue Liu, Jing Zhao, Yingkai Zhang, Iban Ubarretxena-Belandia, Scott Forth, Raquel L. Lieberman, Chunyu Wang. Substrate–Enzyme Interactions in Intramembrane Proteolysis: γ-Secretase as the Prototype. Frontiers in Molecular Neuroscience 2020, 13 https://doi.org/10.3389/fnmol.2020.00065
  62. Md. Sahab Uddin, Md. Tanvir Kabir, Philippe Jeandet, Bijo Mathew, Ghulam Md Ashraf, Asma Perveen, May N. Bin-Jumah, Shaker A. Mousa, Mohamed M. Abdel-Daim. Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing. Oxidative Medicine and Cellular Longevity 2020, 2020 , 1-19. https://doi.org/10.1155/2020/7039138
  63. Johannes Trambauer, Akio Fukumori, Harald Steiner. Pathogenic Aβ generation in familial Alzheimer’s disease: novel mechanistic insights and therapeutic implications. Current Opinion in Neurobiology 2020, 61 , 73-81. https://doi.org/10.1016/j.conb.2020.01.011
  64. Aida Iraji, Mahsima Khoshneviszadeh, Omidreza Firuzi, Mehdi Khoshneviszadeh, Najmeh Edraki. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. Bioorganic Chemistry 2020, 97 , 103649. https://doi.org/10.1016/j.bioorg.2020.103649
  65. Johannes Trambauer, Rosa María Rodríguez Sarmiento, Akio Fukumori, Regina Feederle, Karlheinz Baumann, Harald Steiner. Aβ43‐producing PS 1 FAD mutants cause altered substrate interactions and respond to γ‐secretase modulation. EMBO reports 2020, 21 (1) https://doi.org/10.15252/embr.201947996
  66. Jae Eun Ahn, Charles Carrieri, Fernando Dela Cruz, Terence Fullerton, Eva Hajos‐Korcsok, Ping He, Constantino Kantaridis, Claire Leurent, Richann Liu, Jessica Mancuso, Laure Mendes da Costa, Ruolun Qiu. Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, PF ‐06648671, on CSF Amyloid‐β Peptides in Randomized Phase I Studies. Clinical Pharmacology & Therapeutics 2020, 107 (1) , 211-220. https://doi.org/10.1002/cpt.1570
  67. Gerhard Multhaup, Filip Liebsch. Alzheimer’s Disease. 2020, 1-6. https://doi.org/10.1007/978-3-030-21573-6_262-1
  68. V. Prakash Reddy. Pharmaceutical applications of organofluorine compounds. 2020, 133-214. https://doi.org/10.1016/B978-0-12-813286-9.00005-5
  69. Fausta Ciccocioppo, Giuseppina Bologna, Eva Ercolino, Laura Pierdomenico, Pasquale Simeone, Paola Lanuti, Damiana Pieragostino, Piero Del Boccio, Marco Marchisio, Sebastiano Miscia. Neurodegenerative diseases as proteinopathies-driven immune disorders. Neural Regeneration Research 2020, 15 (5) , 850. https://doi.org/10.4103/1673-5374.268971
  70. Elizabeth Joe, John M Ringman. Cognitive symptoms of Alzheimer’s disease: clinical management and prevention. BMJ 2019, 25 , l6217. https://doi.org/10.1136/bmj.l6217
  71. David Vanda, Paweł Zajdel, Miroslav Soural. Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. European Journal of Medicinal Chemistry 2019, 181 , 111569. https://doi.org/10.1016/j.ejmech.2019.111569
  72. Pedro de Sena M. Pinheiro, Daniel A. Rodrigues, Rodolfo do Couto Maia, Sreekanth Thota, Carlos A.M. Fraga. The Use of Conformational Restriction in Medicinal Chemistry. Current Topics in Medicinal Chemistry 2019, 19 (19) , 1712-1733. https://doi.org/10.2174/1568026619666190712205025
  73. Carlo Cusulin, Isabelle Wells, Solveig Badillo, Gonzalo Christian Duran-Pacheco, Karlheinz Baumann, Christoph Patsch. Gamma secretase modulators and BACE inhibitors reduce Aβ production without altering gene expression in Alzheimer's disease iPSC-derived neurons and mice. Molecular and Cellular Neuroscience 2019, 100 , 103392. https://doi.org/10.1016/j.mcn.2019.103392
  74. Nalini Schaduangrat, Veda Prachayasittikul, Saowapak Choomwattana, Prapimpun Wongchitrat, Kamonrat Phopin, Wilasinee Suwanjang, Aijaz Ahmad Malik, Bruno Vincent, Chanin Nantasenamat. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. Medicinal Research Reviews 2019, 39 (5) , 1730-1778. https://doi.org/10.1002/med.21563
  75. David S. Reynolds. A short perspective on the long road to effective treatments for Alzheimer's disease. British Journal of Pharmacology 2019, 176 (18) , 3636-3648. https://doi.org/10.1111/bph.14581
  76. Guilherme Martins Silva, Mariana Pegrucci Barcelos, João Gabriel Curtolo Poiani, Lorane Izabel da Silva Hage‐Melim, Carlos Henrique Tomich de Paula da Silva. Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review. ChemMedChem 2019, 14 (16) , 1467-1483. https://doi.org/10.1002/cmdc.201900299
  77. Manuel A. Castro, Arina Hadziselimovic, Charles R. Sanders. The vexing complexity of the amyloidogenic pathway. Protein Science 2019, 28 (7) , 1177-1193. https://doi.org/10.1002/pro.3606
  78. Rosa Anna Vacca, Sweta Bawari, Daniela Valenti, Devesh Tewari, Seyed Fazel Nabavi, Samira Shirooie, Archana N. Sah, Mariateresa Volpicella, Nady Braidy, Seyed Mohammad Nabavi. Down syndrome: Neurobiological alterations and therapeutic targets. Neuroscience & Biobehavioral Reviews 2019, 98 , 234-255. https://doi.org/10.1016/j.neubiorev.2019.01.001
  79. Miguel Maia, Emília Sousa. BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease. Pharmaceuticals 2019, 12 (1) , 41. https://doi.org/10.3390/ph12010041
  80. Kejing Lao, Naichun Ji, Xiaohua Zhang, Wenwei Qiao, Zhishu Tang, Xingchun Gou. Drug development for Alzheimer’s disease: review. Journal of Drug Targeting 2019, 27 (2) , 164-173. https://doi.org/10.1080/1061186X.2018.1474361
  81. Noralyn Basco Mañucat-Tan, Khalil Saadipour, Yan-Jiang Wang, Larisa Bobrovskaya, Xin-Fu Zhou. Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance. Molecular Neurobiology 2019, 56 (2) , 812-830. https://doi.org/10.1007/s12035-018-1106-9
  82. Michael S. Wolfe. Dysfunctional γ-Secretase in Familial Alzheimer’s Disease. Neurochemical Research 2019, 44 (1) , 5-11. https://doi.org/10.1007/s11064-018-2511-1
  83. Ram W. Sabnis. Patents on Natural Products for Diagnosing/Preventing/Treating Alzheimer's Disease. 2019, 85-141. https://doi.org/10.1016/B978-0-444-64183-0.00003-8
  84. Maria Z. Kounnas, Murat S. Durakoglugil, Joachim Herz, William T. Comer. NGP 555, a γ‐secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2019, 5 (1) , 458-467. https://doi.org/10.1016/j.trci.2019.06.006
  85. Evgeniy Salnikov, Binia Drung, Gabin Fabre, Anna Itkin, Michal Otyepka, Norbert A. Dencher, Boris Schmidt, Thomas Hauß, Patrick Trouillas, Burkhard Bechinger. Lipid bilayer position and orientation of novel carprofens, modulators of γ-secretase in Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Biomembranes 2018, 1860 (11) , 2224-2233. https://doi.org/10.1016/j.bbamem.2018.09.003
  86. Deepti Goyal, Amandeep Kaur, Bhupesh Goyal. Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease. ChemMedChem 2018, 13 (13) , 1275-1299. https://doi.org/10.1002/cmdc.201800156
  87. Kai Gerlach, Scott Hobson, Christian Eickmeier, Ulrike Groß, Clemens Braun, Peter Sieger, Michel Garneau, Stefan Hoerer, Niklas Heine. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators. Bioorganic & Medicinal Chemistry 2018, 26 (12) , 3227-3241. https://doi.org/10.1016/j.bmc.2018.04.053
  88. Devendra Kumar, Ankit Ganeshpurkar, Dileep Kumar, Gyan Modi, Sanjeev Kumar Gupta, Sushil Kumar Singh. Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead. European Journal of Medicinal Chemistry 2018, 148 , 436-452. https://doi.org/10.1016/j.ejmech.2018.02.035
  89. Ean-Jeong Seo, Nicolas Fischer, Thomas Efferth. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease. Pharmacological Research 2018, 129 , 262-273. https://doi.org/10.1016/j.phrs.2017.11.030
  90. Akio Fukumori, Johannes Trambauer, Lukas P. Feilen, Harald Steiner. Identifizierung von Substratbindestellen in der γ-Sekretase. BIOspektrum 2018, 24 (1) , 34-36. https://doi.org/10.1007/s12268-018-0888-7
  91. Tetsuo Cai, Masahiro Yonaga, Taisuke Tomita. Activation of γ-Secretase Trimming Activity by Topological Changes of Transmembrane Domain 1 of Presenilin 1. The Journal of Neuroscience 2017, 37 (50) , 12272-12280. https://doi.org/10.1523/JNEUROSCI.1628-17.2017
  92. Katarzyna Marta Zoltowska, Masato Maesako, Iryna Lushnikova, Shuko Takeda, Laura J. Keller, Galina Skibo, Bradley T. Hyman, Oksana Berezovska. Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β production. Molecular Neurodegeneration 2017, 12 (1) https://doi.org/10.1186/s13024-017-0159-y
  93. Alan S. Robertson, Lawrence G. Iben, Cong Wei, Jere E. Meredith, Dieter M. Drexler, Martyn Banks, Gregory D. Vite, Richard E. Olson, Lorin A. Thompson, Charles F. Albright, Michael K. Ahlijanian, Jeremy H. Toyn. Synergistic inhibition of Aβ production by combinations of γ-secretase modulators. European Journal of Pharmacology 2017, 812 , 104-112. https://doi.org/10.1016/j.ejphar.2017.07.019
  94. Nguyen Quoc Thai, Hoang Linh Nguyen, Huynh Quang Linh, Mai Suan Li. Protocol for fast screening of multi-target drug candidates: Application to Alzheimer’s disease. Journal of Molecular Graphics and Modelling 2017, 77 , 121-129. https://doi.org/10.1016/j.jmgm.2017.08.002
  95. Ayesha Khan, Anne Corbett, Clive Ballard. Emerging amyloid and tau targeting treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics 2017, 17 (7) , 697-711. https://doi.org/10.1080/14737175.2017.1326819
  96. Rodrigo Aguayo-Ortiz, Laura Dominguez. Generation of Amyloid-β Peptides by γ-Secretase. Israel Journal of Chemistry 2017, 57 (7-8) , 574-585. https://doi.org/10.1002/ijch.201600073
  97. Steven H. L. Verhelst. Intramembrane proteases as drug targets. The FEBS Journal 2017, 284 (10) , 1489-1502. https://doi.org/10.1111/febs.13979
  98. Dieter Langosch, Harald Steiner. Substrate processing in intramembrane proteolysis by γ-secretase – the role of protein dynamics. Biological Chemistry 2017, 398 (4) , 441-453. https://doi.org/10.1515/hsz-2016-0269
  99. A. Hall, A.I. Velter. Targeting γ-Secretase for the Treatment of Alzheimer’s Disease. 2017, 280-325. https://doi.org/10.1016/B978-0-12-409547-2.13789-8
  100. J. Trambauer, A. Fukumori, B. Kretner, H. Steiner. Analyzing Amyloid-β Peptide Modulation Profiles and Binding Sites of γ-Secretase Modulators. 2017, 157-183. https://doi.org/10.1016/bs.mie.2016.10.013
Load all citations

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect